This revealed the presence of AP2S1 mutations in 17 probands (7 males and 10 females), thereby representing a >25% AP2S1 mutation detection rate in this cohort of FHH patients without CASR and GNA11 mutations. Here, AP2S1 is linked to familial hypocalciuric hypercalcemia.